Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
3.32%
operating margin TTM
5.48%
revenue TTM
419.68 Million
revenue per share TTM
1.36$
valuation ratios | |
|---|---|
| pe ratio | 220.08 |
| peg ratio | 3.37 |
| price to book ratio | 18.98 |
| price to sales ratio | 7.31 |
| enterprise value multiple | 114.99 |
| price fair value | 18.98 |
profitability ratios | |
|---|---|
| gross profit margin | 89.77% |
| operating profit margin | 5.48% |
| pretax profit margin | 0.83% |
| net profit margin | 3.32% |
| return on assets | 2.29% |
| return on equity | 9.67% |
| return on capital employed | 4.9% |
liquidity ratios | |
|---|---|
| current ratio | 2.99 |
| quick ratio | 2.09 |
| cash ratio | 0.96 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 1,060.86 |
| operating cycle | 1,130.26 |
| days of payables outstanding | 113.90 |
| cash conversion cycle | 1,016.36 |
| receivables turnover | 5.26 |
| payables turnover | 3.20 |
| inventory turnover | 0.34 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.51 |
| debt equity ratio | 1.92 |
| long term debt to capitalization | 0.65 |
| total debt to capitalization | 0.66 |
| interest coverage | 1.41 |
| cash flow to debt ratio | 0.03 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.03 |
| cash per share | 0.86 |
| operating cash flow per share | 0.04 |
| free cash flow operating cash flow ratio | 0.75 |
| cash flow coverage ratios | 0.03 |
| short term coverage ratios | 1.50 |
| capital expenditure coverage ratio | 3.95 |
Frequently Asked Questions
When was the last time Amicus Therapeutics, Inc. (NASDAQ:FOLD) reported earnings?
Amicus Therapeutics, Inc. (FOLD) published its most recent earnings results on 04-11-2025.
What is Amicus Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Amicus Therapeutics, Inc. (NASDAQ:FOLD)'s trailing twelve months ROE is 9.67%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Amicus Therapeutics, Inc. (FOLD) currently has a ROA of 2.29%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did FOLD's net profit margin stand at?
FOLD reported a profit margin of 3.32% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is FOLD's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.99 in the most recent quarter. The quick ratio stood at 2.09, with a Debt/Eq ratio of 1.92.